{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:01:20Z","timestamp":1781103680080,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Electrocardiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jelectrocard.2018.08.035","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T02:23:47Z","timestamp":1535682227000},"page":"1061-1065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The role of mexiletine in the management of long QT syndrome"],"prefix":"10.1016","volume":"51","author":[{"given":"Guoliang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-6730","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCEP.111.962019","article-title":"Long-QT syndrome: from genetics to management","volume":"5","author":"Schwartz","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0010","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1161\/01.CIR.102.23.2849","article-title":"Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes","volume":"102","author":"Zhang","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0015","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000440608","article-title":"Common genotypes of long QT syndrome in China and the role of ECG prediction","volume":"133","author":"Gao","year":"2016","journal-title":"Cardiology"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome \u2014 gene-specific triggers for life-threatening arrhythmias","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0030","doi-asserted-by":"crossref","unstructured":"Yin C, Zhang P, Yang J, Zhang L. Unique ECG presentations and clinical management of a symptomatic LQT2 female carrying a novel de novo KCNH2 mutation. J Electrocardiol 2017.","DOI":"10.1016\/j.jelectrocard.2017.08.022"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0035","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","article-title":"Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers","volume":"292","author":"Priori","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0040","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.jacc.2008.02.068","article-title":"Long QT syndrome","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jelectrocard.2017.02.003","article-title":"Insights into channelopathies: progress in clinical practice and research","volume":"50","author":"Matusik","year":"2017","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0050","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0735-1097(87)80203-6","article-title":"Permanent cardiac pacing in patients with the long QT syndrome","volume":"10","author":"Eldar","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0055","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/01.CIR.100.24.2431","article-title":"Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing","volume":"100","author":"Dorostkar","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/cvr\/cvp083","article-title":"Re-evaluating the efficacy of beta-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling","volume":"82","author":"Ahrens-Nicklas","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0065","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0735-1097(99)00582-3","article-title":"Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome","volume":"35","author":"Shimizu","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0070","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1511643","article-title":"A leadless intracardiac transcatheter pacing system","volume":"374","author":"Reynolds","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1085\/jgp.86.1.89","article-title":"Slow currents through single sodium channels of the adult rat heart","volume":"86","author":"Patlak","year":"1985","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0080","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/01.CIR.98.23.2545","article-title":"Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes","volume":"98","author":"Maltsev","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-642-41588-3_7","article-title":"The role of late I Na in development of cardiac arrhythmias","volume":"221","author":"Antzelevitch","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0090","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI0215928","article-title":"Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome","volume":"110","author":"Clancy","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/cvr\/cvt145","article-title":"The arrhythmogenic consequences of increasing late INa in the cardiomyocyte","volume":"99","author":"Shryock","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0100","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1006\/jmcc.2002.2100","article-title":"Gating of the late Na+ channel in normal and failing human myocardium","volume":"34","author":"Undrovinas","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.RES.64.2.389","article-title":"Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes","volume":"64","author":"Kiyosue","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(95)90359-3","article-title":"SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome","volume":"80","author":"Wang","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.yjmcc.2004.12.012","article-title":"Increased late sodium current in myocytes from a canine heart failure model and from failing human heart","volume":"38","author":"Valdivia","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0120","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.hrthm.2015.02.013","article-title":"Heterogeneous distribution of INa-L determines interregional differences in rate adaptation of repolarization","volume":"12","author":"Qi","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0125","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.110.000661","article-title":"Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization","volume":"123","author":"Wu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0130","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/1535370218777972","article-title":"Dysfunctional Nav1.5 channels due to SCN5A mutations","volume":"243","author":"Han","year":"2018","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0135","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/01.CIR.96.6.2038","article-title":"Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome","volume":"96","author":"Shimizu","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0140","doi-asserted-by":"crossref","first-page":"H689","DOI":"10.1152\/ajpheart.2001.281.2.H689","article-title":"Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle","volume":"281","author":"Zygmunt","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0145","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCEP.113.000092","article-title":"Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome","volume":"6","author":"Gao","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacep.2015.05.008","article-title":"Mexiletine prevents recurrent torsades de pointes in acquired long QT syndrome refractory to conventional measures","volume":"1","author":"Badri","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jelectrocard.2016.09.005","article-title":"The effects of pure potassium channel blocker nifekalant and sodium channel blocker mexiletine on malignant ventricular tachyarrhythmias","volume":"50","author":"Otuki","year":"2017","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3349\/ymj.2013.54.2.529","article-title":"A case of long QT syndrome type 3 aggravated by beta-blockers and alleviated by mexiletine: the role of epinephrine provocation test","volume":"54","author":"Park","year":"2013","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0165","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0170","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","article-title":"Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients","volume":"116","author":"Ruan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0175","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1253\/circj.CJ-15-0984","article-title":"Pronounced shortening of QT interval with mexiletine infusion test in patients with type 3 congenital long QT syndrome","volume":"80","author":"Funasako","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0180","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1161\/01.CIR.92.12.3381","article-title":"Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy","volume":"92","author":"Schwartz","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0185","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1124\/jpet.104.066100","article-title":"Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome","volume":"310","author":"Wu","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pbiomolbio.2009.01.003","article-title":"Sinus node dysfunction in ATX-II-induced in-vitro murine model of long QT3 syndrome and rescue effect of ranolazine","volume":"98","author":"Wu","year":"2008","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0195","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.hrthm.2013.03.023","article-title":"Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967","volume":"10","author":"Sicouri","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1476-5381.2010.00884.x","article-title":"Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias","volume":"161","author":"Pignier","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0205","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.hrthm.2016.10.021","article-title":"Eleclazine, an inhibitor of the cardiac late sodium current, is superior to flecainide in suppressing catecholamine-induced ventricular tachycardia and T-wave alternans in an intact porcine model","volume":"14","author":"Bacic","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1476-5381.2008.00062.x","article-title":"F 15845 inhibits persistent sodium current in the heart and prevents angina in animal models","volume":"156","author":"Vacher","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jelectrocard.2018.08.035_bb0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.112.198887","article-title":"A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias","volume":"344","author":"Belardinelli","year":"2013","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Electrocardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073618301997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073618301997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T12:30:02Z","timestamp":1758285002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022073618301997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0022073618301997"],"URL":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2018.08.035","relation":{},"ISSN":["0022-0736"],"issn-type":[{"value":"0022-0736","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of mexiletine in the management of long QT syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Electrocardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2018.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}